{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:03:32Z","timestamp":1788797012565,"version":"build-2803163510"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41433-025-03801-6","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:16:26Z","timestamp":1745050586000},"page":"1662-1672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Updates on novel and traditional OCT and OCTA biomarkers in nAMD"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9996-9871","authenticated-orcid":false,"given":"Emanuele","family":"Crincoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Parravano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-2012","authenticated-orcid":false,"given":"Riccardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ferro Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9581","authenticated-orcid":false,"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"3801_CR1","doi-asserted-by":"crossref","unstructured":"Korva-Gurung I, Kubin AM, Ohtonen P, Hautala N Incidence and prevalence of neovascular age-related macular degeneration: 15-year epidemiological study in a population-based cohort in Finland. Annals of Medicine [Internet]. 2023 Dec 12 [cited 2024 May 1]; Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/07853890.2023.2222545.","DOI":"10.1080\/07853890.2023.2222545"},{"key":"3801_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.ophtha.2021.07.025","volume":"128","author":"S Sivaprasad","year":"2021","unstructured":"Sivaprasad S, Banister K, Azuro-Blanco A, Goulao B, Cook JA, Hogg R, et al. Diagnostic accuracy of monitoring tests of fellow eyes in patients with unilateral neovascular age-related macular degeneration: early detection of neovascular age-related macular degeneration study. Ophthalmology. 2021;128:1736\u201347.","journal-title":"Ophthalmology"},{"key":"3801_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/VLFL1739","volume":"26","author":"K Banister","year":"2022","unstructured":"Banister K, Cook JA, Scotland G, Azuara-Blanco A, Goul\u00e3o B, Heimann H, et al. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study. Health Technol Assess. 2022;26:1\u2013142.","journal-title":"Health Technol Assess"},{"key":"3801_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ophtha.2017.01.018","volume":"124","author":"E Maggio","year":"2017","unstructured":"Maggio E, Polito A, Guerriero M, Prigione G, Parolini B, Pertile G. Vitreomacular adhesion and the risk of neovascular age-related macular degeneration. Ophthalmology. 2017;124:657\u201366.","journal-title":"Ophthalmology"},{"key":"3801_CR5","doi-asserted-by":"crossref","unstructured":"Horozoglu Ceran T, Sonmez K, Kirtil G. The impact of vitreomacular traction on vitreous vascular endothelial growth factor and placental growth factor levels in neovascular age-related macular degeneration patients. Eye. 2024;11:1\u20136.","DOI":"10.1038\/s41433-024-03456-9"},{"key":"3801_CR6","doi-asserted-by":"crossref","unstructured":"Ruggeri ML, Toto L, Zeppa L, Gironi M, Quarta A, Venturoni P, et al. Impact of vitreomacular interface on intravitreal Brolucizumab efficacy in age-related macular neovascularization. Eur J Ophthalmol. 2024;16:11206721241282429.","DOI":"10.1177\/11206721241282429"},{"key":"3801_CR7","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.ophtha.2013.05.032","volume":"120","author":"U Mayr-Sponer","year":"2013","unstructured":"Mayr-Sponer U, Waldstein SM, Kundi M, Ritter M, Golbaz I, Heiling U, et al. Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration. Ophthalmology. 2013;120:2620\u20139.","journal-title":"Ophthalmology"},{"key":"3801_CR8","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.4103\/ijo.IJO_373_18","volume":"66","author":"M Neudorfer","year":"2018","unstructured":"Neudorfer M, Fuhrer AE, Zur D, Barak A. The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration. Indian J Ophthalmol. 2018;66:1802\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"3801_CR9","unstructured":"Svasti-Salee CR, Snead MP, Alexander P. Response to \u2019Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration. 2025 Feb 18 [cited 2025 Feb 18]; Available from: https:\/\/bjo.bmj.com\/content\/response-effect-posterior-vitreous-detachment-treat-and-extend-versus-monthly-ranibizumab."},{"key":"3801_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-021-00342-4","volume":"7","author":"M Miyata","year":"2021","unstructured":"Miyata M, Ooto S, Yamashiro K, Tamura H, Uji A, Miyake M, et al. Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration. Int J Retin Vitreous. 2021;7:77.","journal-title":"Int J Retin Vitreous"},{"key":"3801_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/APO.0000000000000157","volume":"5","author":"RB Rush","year":"2016","unstructured":"Rush RB, Rush SW. Ranibizumab versus bevacizumab for neovascular age-related macular degeneration with an incomplete posterior vitreous detachment. Asia Pac J Ophthalmol. 2016;5:171\u20135.","journal-title":"Asia Pac J Ophthalmol"},{"key":"3801_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/OPTH.S403242","volume":"17","author":"A Bakaliou","year":"2023","unstructured":"Bakaliou A, Georgakopoulos C, Tsilimbaris M, Farmakakis N. Posterior vitreous detachment and its role in the evolution of dry to wet age related macular degeneration. Clin Ophthalmol. 2023;17:879\u201385.","journal-title":"Clin Ophthalmol"},{"key":"3801_CR13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.ophtha.2008.04.041","volume":"115","author":"AA Khanifar","year":"2008","unstructured":"Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115:1883\u20131890.e1.","journal-title":"Ophthalmology"},{"key":"3801_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6096017","volume":"2021","author":"S Fragiotta","year":"2021","unstructured":"Fragiotta S, Abdolrahimzadeh S, Dolz-Marco R, Sakurada Y, Gal-Or O, Scuderi G. Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications. J Ophthalmol. 2021;2021:e6096017.","journal-title":"J Ophthalmol"},{"key":"3801_CR15","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.ophtha.2015.07.008","volume":"122","author":"CE Pang","year":"2015","unstructured":"Pang CE, Messinger JD, Zanzottera EC, Freund KB, Curcio CA. The onion sign in neovascular age-related macular degeneration represents cholesterol crystals. Ophthalmology. 2015;122:2316\u201326.","journal-title":"Ophthalmology"},{"key":"3801_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000342159","volume":"229","author":"G Coscas","year":"2012","unstructured":"Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, et al. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2012;229:32\u20137.","journal-title":"Ophthalmologica"},{"key":"3801_CR17","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00417-020-04837-y","volume":"258","author":"L Tiosano","year":"2020","unstructured":"Tiosano L, Byon I, Alagorie AR, Ji YS, Sadda SR. Choriocapillaris flow deficit associated with intraretinal hyperreflective foci in intermediate age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2020;258:2353\u201362.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3801_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/IAE.0000000000002531","volume":"40","author":"X Hu","year":"2020","unstructured":"Hu X, Waldstein SM, Klimscha S, Sadeghipour A, Bogunovic H, Gerendas BS, et al. Morphological and functional characteristics at the onset of exudative conversion in age-related macular degeneration. Retina. 2020;40:1070.","journal-title":"Retina"},{"key":"3801_CR19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.oret.2018.04.016","volume":"2","author":"R Sacconi","year":"2018","unstructured":"Sacconi R, Sarraf D, Garrity S, Freund KB, Yannuzzi LA, Gal-Or O, et al. Nascent type 3 neovascularization in age-related macular degeneration. Ophthalmol Retin. 2018;2:1097\u2013106.","journal-title":"Ophthalmol Retin"},{"key":"3801_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamaophthalmol.2020.1376","volume":"138","author":"SM Waldstein","year":"2020","unstructured":"Waldstein SM, Vogl WD, Bogunovic H, Sadeghipour A, Riedl S, Schmidt-Erfurth U. Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography. JAMA Ophthalmol. 2020;138:740\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"3801_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/IAE.0000000000003958","volume":"44","author":"KL Goh","year":"2024","unstructured":"Goh KL, Wintergerst MWM, Abbott CJ, Hadoux X, Jannaud M, Kumar H, et al. Hyperreflective foci not seen as hyperpigmentary abnormalities on color fundus photographs in age-related macular degeneration. Retina. 2024;44:214.","journal-title":"Retina"},{"key":"3801_CR22","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1111\/aos.15708","volume":"102","author":"D Oncel","year":"2024","unstructured":"Oncel D, Corradetti G, He Y, Ashrafkhorasani M, Nittala MG, Stambolian D, et al. Assessment of intraretinal hyperreflective foci using multimodal imaging in eyes with age-related macular degeneration. Acta Ophthalmol. 2024;102:e126\u201332.","journal-title":"Acta Ophthalmol"},{"key":"3801_CR23","doi-asserted-by":"crossref","unstructured":"Herrera G, Cheng Y, Attiku Y, Hiya FE, Shen M, Liu J, et al. Comparison between spectral-domain and swept-source OCT angiography scans for the measurement of hyperreflective foci in AMD. Ophthalmol Sci. 2024;21:100633.","DOI":"10.1016\/j.xops.2024.100633"},{"key":"3801_CR24","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00417-012-1928-5","volume":"250","author":"Y Akagi-Kurashige","year":"2012","unstructured":"Akagi-Kurashige Y, Tsujikawa A, Oishi A, Ooto S, Yamashiro K, Tamura H, et al. Relationship between retinal morphological findings and visual function in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012;250:1129\u201336.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3801_CR25","first-page":"750","volume":"17","author":"O Segal","year":"2015","unstructured":"Segal O, Ferencz JR, Mimouni M, Nesher R, Cohen P, Nemet AY. Lamellar macular holes associated with end-stage exudative age-related macular degeneration. Isr Med Assoc J. 2015;17:750\u20134.","journal-title":"Isr Med Assoc J"},{"key":"3801_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","volume":"128","author":"G Moraes","year":"2021","unstructured":"Moraes G, Fu DJ, Wilson M, Khalid H, Wagner SK, Korot E, et al. Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning. Ophthalmology. 2021;128:693\u2013705.","journal-title":"Ophthalmology"},{"key":"3801_CR27","first-page":"4388","volume":"65","author":"Y nakanishi","year":"2024","unstructured":"nakanishi Y, Tsujikawa A, Tamura H, Miyata M, Hata M, Kogo T, et al. Association of hyperreflective foci and subretinal fibrosis in neovascular age-related macular degeneration. Investig Ophthalmol Vis Sci. 2024;65:4388.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR28","doi-asserted-by":"crossref","unstructured":"Wan Z, Wu Y, Shen T, Hu C, Lin R, Ren C, et al. Evaluation of inflammatory hyperreflective foci and plasma EPA as diagnostic and predictive markers for age-related macular degeneration. Front Neurosci. 2024 Oct 10 [cited 2024 Nov 7];18. Available from: https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/10.3389\/fnins.2024.1401101\/full.","DOI":"10.3389\/fnins.2024.1401101"},{"key":"3801_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00508-020-01718-6","volume":"133","author":"C Ebner","year":"2021","unstructured":"Ebner C, Wernigg C, Sch\u00fctze C, Weingessel B, V\u00e9csei-Marlovits PV. Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration. Wien Klin Wochenschr. 2021;133:123\u201330.","journal-title":"Wien Klin Wochenschr"},{"key":"3801_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000477856","volume":"238","author":"C T\u00fcrksever","year":"2017","unstructured":"T\u00fcrksever C, Pr\u00fcnte C, Hatz K. Baseline optical coherence tomography findings as outcome predictors after switching from ranibizumab to aflibercept in neovascular age-related macular degeneration following a treat-and-extend regimen. Ophthalmologica. 2017;238:172\u20138.","journal-title":"Ophthalmologica"},{"key":"3801_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00417-021-05419-2","volume":"260","author":"S Amarasekera","year":"2022","unstructured":"Amarasekera S, Samanta A, Jhingan M, Arora S, Singh S, Tucci D, et al. Optical coherence tomography predictors of progression of non-exudative age-related macular degeneration to advanced atrophic and exudative disease. Graefes Arch Clin Exp Ophthalmol. 2022;260:737\u201346.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3801_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/IAE.0000000000003945","volume":"44","author":"E Bousquet","year":"2024","unstructured":"Bousquet E, Santina A, Corradetti G, Sacconi R, Ramtohul P, Bijon J, et al. From drusen to type 3 macular neovascularization. Retina. 2024;44:189.","journal-title":"Retina"},{"key":"3801_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32184-5","volume":"13","author":"S Lee","year":"2023","unstructured":"Lee S, Kim KT, Kim DY, Chae JB, Seo EJ. Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration. Sci Rep. 2023;13:5045.","journal-title":"Sci Rep"},{"key":"3801_CR34","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/IAE.0000000000001688","volume":"38","author":"A Oishi","year":"2018","unstructured":"Oishi A, Fang PP, Thiele S, Holz FG, Krohne TU. Longitudinal change of outer nuclear layer after retinal pigment epithelial tear secondary to age-related macular degeneration. Retina. 2018;38:1331.","journal-title":"Retina"},{"key":"3801_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/518170","volume":"2013","author":"Y Mitamura","year":"2013","unstructured":"Mitamura Y, Mitamura-Aizawa S, Katome T, Naito T, Hagiwara A, Kumagai K, et al. Photoreceptor impairment and restoration on optical coherence tomographic image. J Ophthalmol. 2013;2013:518170.","journal-title":"J Ophthalmol"},{"key":"3801_CR36","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ophtha.2020.03.010","volume":"127","author":"U Schmidt-Erfurth","year":"2020","unstructured":"Schmidt-Erfurth U, Vogl WD, Jampol LM, Bogunovi\u0107 H. Application of automated quantification of fluid volumes to anti\u2013VEGF therapy of neovascular age-related macular degeneration. Ophthalmology. 2020;127:1211\u20139.","journal-title":"Ophthalmology"},{"key":"3801_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/aos.13565","volume":"96","author":"M Ashraf","year":"2018","unstructured":"Ashraf M, Souka A, Adelman RA. Age-related macular degeneration: using morphological predictors to modify current treatment protocols. Acta Ophthalmol. 2018;96:120\u201333.","journal-title":"Acta Ophthalmol"},{"key":"3801_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ophtha.2018.11.025","volume":"126","author":"RH Guymer","year":"2019","unstructured":"Guymer RH, Markey CM, McAllister IL, Gillies MC, Hunyor AP, Arnold JJ, et al. Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID study 24-month results. Ophthalmology. 2019;126:723\u201334.","journal-title":"Ophthalmology"},{"key":"3801_CR39","first-page":"1285","volume":"64","author":"V Mares","year":"2023","unstructured":"Mares V, Reiter GS, Bogunovic H, Leingang O, Barthelmes D, Schmidt-Erfurth U. AI-based retinal fluid monitoring correlated with automated photoreceptor loss quantification in neovascular AMD in the fight retinal blindness! registry. Investig Ophthalmol Vis Sci. 2023;64:1285.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100972","volume":"86","author":"U Schmidt-Erfurth","year":"2022","unstructured":"Schmidt-Erfurth U, Reiter GS, Riedl S, Seeb\u00f6ck P, Vogl WD, Blodi BA, et al. AI-based monitoring of retinal fluid in disease activity and under therapy. Prog Retinal Eye Res. 2022;86:100972.","journal-title":"Prog Retinal Eye Res"},{"key":"3801_CR41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.oret.2018.01.005","volume":"2","author":"JJ Lek","year":"2018","unstructured":"Lek JJ, Caruso E, Baglin EK, Sharangan P, Hodgson LAB, Harper CA, et al. Interpretation of subretinal fluid using OCT in intermediate age-related macular degeneration. Ophthalmol Retin. 2018;2:792\u2013802.","journal-title":"Ophthalmol Retin"},{"key":"3801_CR42","unstructured":"Zur D, Guymer R, Korobelnik JF, Wu L, Viola F, Eter N, et al. Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration. Br J Ophthalmol [Internet]. 2024 Jul 19 [cited 2024 Nov 7]; Available from: https:\/\/bjo.bmj.com\/content\/early\/2024\/08\/01\/bjo-2024-325640."},{"key":"3801_CR43","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archophthalmol.2009.326","volume":"127","author":"SA Zweifel","year":"2009","unstructured":"Zweifel SA, Engelbert M, Laud K, Margolis R, Spaide RF, Freund KB. Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol. 2009;127:1596\u2013602.","journal-title":"Arch Ophthalmol"},{"key":"3801_CR44","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1097\/IAE.0000000000000471","volume":"35","author":"KB Schaal","year":"2015","unstructured":"Schaal KB, Freund KB, Litts KM, Zhang Y, Messinger JD, Curcio CA. Outer retinal tubulation in advanced age-related macular degeneration: optical coherence tomographic findings correspond to histology. Retina. 2015;35:1339\u201350.","journal-title":"Retina"},{"key":"3801_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9994098","volume":"2021","author":"C Metrangolo","year":"2021","unstructured":"Metrangolo C, Donati S, Mazzola M, Fontanel L, Messina W, D\u2019alterio G, et al. OCT biomarkers in neovascular age-related macular degeneration: a narrative review. J Ophthalmol. 2021;2021:9994098.","journal-title":"J Ophthalmol"},{"key":"3801_CR46","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.ophtha.2014.06.013","volume":"121","author":"JY Lee","year":"2014","unstructured":"Lee JY, Folgar FA, Maguire MG, Ying GS, Toth CA, Martin DF, et al. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2014;121:2423\u201331.","journal-title":"Ophthalmology"},{"key":"3801_CR47","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/IAE.0000000000000439","volume":"35","author":"A Dirani","year":"2015","unstructured":"Dirani A, Gianniou C, Marchionno L, Decugis D, Mantel I. Incidence of outer retinal tubulation in ranibizumab-treated age-related macular degeneration. Retina. 2015;35:1166\u201372.","journal-title":"Retina"},{"key":"3801_CR48","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.oret.2024.02.007","volume":"8","author":"S Yordi","year":"2024","unstructured":"Yordi S, Cakir Y, Cetin H, Talcott KE, Srivastava SK, Hu J, et al. Bacillary layer detachment in neovascular age-related macular degeneration from a phase III clinical trial. Ophthalmol Retin. 2024;8:754\u201364.","journal-title":"Ophthalmol Retin"},{"key":"3801_CR49","unstructured":"Feo A, Stradiotto E, Sacconi R, Menean M, Querques G, Romano MR Subretinal hyperreflective material in retinal and chorioretinal disorders: a comprehensive review. Survey of Ophthalmology [Internet]. 2023 Dec 29 [cited 2024 Apr 7]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0039625723001698."},{"key":"3801_CR50","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/IAE.0000000000001748","volume":"38","author":"R Pokroy","year":"2018","unstructured":"Pokroy R, Mimouni M, Barayev E, Segev F, Geffen N, Nemet AY, et al. Prognostic value of subretinal hyperreflective material in neovascular age-related macular degeneration treated with bevacizumab. Retina. 2018;38:1485\u201391.","journal-title":"Retina"},{"key":"3801_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ajo.2017.06.015","volume":"181","author":"Y Kawashima","year":"2017","unstructured":"Kawashima Y, Hata M, Oishi A, Ooto S, Yamashiro K, Tamura H, et al. Association of vascular versus avascular subretinal hyperreflective material with aflibercept response in age-related macular degeneration. Am J Ophthalmol. 2017;181:61\u201370.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/IAE.0000000000002552","volume":"40","author":"JB Kumar","year":"2020","unstructured":"Kumar JB, Stinnett S, Han JIL, Jaffe GJ. Correlation of subretinal hyperreflective material morphology and visual acuity in neovascular age-related macular degeneration. Retina. 2020;40:845\u201356.","journal-title":"Retina"},{"key":"3801_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajo.2023.12.011","volume":"261","author":"KYC Teo","year":"2024","unstructured":"Teo KYC, Zhao J, Ibrahim FI, Fenner B, Chakravarthy U, Cheung CMG. Features associated with vision in eyes with subfoveal fibrosis from neovascular age-related macular degeneration. Am J Ophthalmol. 2024;261:121\u201331.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2024.06.019","volume":"267","author":"J Pu","year":"2024","unstructured":"Pu J, Zhuang X, Li M, Zhang X, Su Y, He G, et al. Analyzing formation and absorption of avascular subretinal hyperreflective material in nAMD from OCTA-based insights. Am J Ophthalmol. 2024;267:192\u2013203.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR55","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.oret.2023.06.024","volume":"7","author":"S Yu","year":"2023","unstructured":"Yu S, Bachmeier I, Hernandez-Sanchez J, Garcia Armendariz B, Ebneter A, Pauleikhoff D, et al. Hyperreflective material boundary remodeling in neovascular age-related macular degeneration: a post hoc analysis of the AVENUE trial. Ophthalmol Retin. 2023;7:990\u20138.","journal-title":"Ophthalmol Retin"},{"key":"3801_CR56","first-page":"PB009","volume":"65","author":"I Bachmeier","year":"2024","unstructured":"Bachmeier I, Yu S, Glittenberg C, Maunz A, Fauser S. Model for resolution of subretinal hyperreflective material (SHRM) in neovascular age-related macular degeneration (nAMD) using deep learning (DL) image segmentation. Investig Ophthalmol Vis Sci. 2024;65:PB009.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR57","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/bjo-2023-323577","volume":"108","author":"S Sadda","year":"2024","unstructured":"Sadda S, Sarraf D, Khanani AM, Tadayoni R, Chang AA, Saffar I, et al. Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER. Br J Ophthalmol. 2024;108:852\u20138.","journal-title":"Br J Ophthalmol"},{"key":"3801_CR58","first-page":"2910","volume":"53","author":"DA Dieaconescu","year":"2012","unstructured":"Dieaconescu DA, Dieaconescu IM, Williams MA, Hogg RE, Chakravarthy U. Drusen height and width are highly predictive markers for progression to neovascular AMD. Investig Ophthalmol Vis Sci. 2012;53:2910.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ophtha.2015.09.016","volume":"123","author":"FA Folgar","year":"2016","unstructured":"Folgar FA, Yuan EL, Sevilla MB, Chiu SJ, Farsiu S, Chew EY, et al. Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration. Ophthalmology. 2016;123:39\u201350.e1.","journal-title":"Ophthalmology"},{"key":"3801_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/bjophthalmol-2016-308422","volume":"101","author":"FG Schlanitz","year":"2017","unstructured":"Schlanitz FG, Baumann B, Kundi M, Sacu S, Baratsits M, Scheschy U, et al. Drusen volume development over time and its relevance to the course of age-related macular degeneration. Br J Ophthalmol. 2017;101:198\u2013203.","journal-title":"Br J Ophthalmol"},{"key":"3801_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.survophthal.2023.10.010","volume":"69","author":"AM Hagag","year":"2024","unstructured":"Hagag AM, Kaye R, Hoang V, Riedl S, Anders P, Stuart B, et al. Systematic review of prognostic factors associated with progression to late age-related macular degeneration: pinnacle study report 2. Surv Ophthalmol. 2024;69:165\u201372.","journal-title":"Surv Ophthalmol"},{"key":"3801_CR62","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.ophtha.2016.02.043","volume":"123","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Daniel E, Maguire MG, Grunwald JE, Martin ER, Martin DF, et al. Pseudodrusen and incidence of late age-related macular degeneration in fellow eyes in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123:1530\u201340.","journal-title":"Ophthalmology"},{"key":"3801_CR63","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1111\/aos.14960","volume":"100","author":"KL Kim","year":"2022","unstructured":"Kim KL, Joo K, Park SJ, Park KH, Woo SJ. Progression from intermediate to neovascular age-related macular degeneration according to drusen subtypes: Bundang AMD cohort study report 3. Acta Ophthalmol. 2022;100:e710\u20138.","journal-title":"Acta Ophthalmol"},{"key":"3801_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajo.2019.07.013","volume":"208","author":"J Lee","year":"2019","unstructured":"Lee J, Choi S, Lee CS, Kim M, Kim SS, Koh HJ, et al. Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types. Am J Ophthalmol. 2019;208:103\u201310.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR65","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/IAE.0000000000002399","volume":"40","author":"Y Sakurada","year":"2020","unstructured":"Sakurada Y, Parikh R, Gal-Or O, Balaratnasingam C, Leong BCS, Tanaka K, et al. CUTICULAR DRUSEN: risk of geographic atrophy and macular neovascularization. RETINA. 2020;40:257.","journal-title":"RETINA"},{"key":"3801_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01651-2","volume":"20","author":"D Ahmed","year":"2020","unstructured":"Ahmed D, Stattin M, Haas AM, Graf A, Krepler K, Ansari-Shahrezaei S. Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration. BMC Ophthalmol. 2020;20:381.","journal-title":"BMC Ophthalmol"},{"key":"3801_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4544","volume":"10","author":"ACS Tan","year":"2018","unstructured":"Tan ACS, Pilgrim MG, Fearn S, Bertazzo S, Tsolaki E, Morrell AP, et al. Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration. Sci Transl Med. 2018;10:eaat4544.","journal-title":"Sci Transl Med"},{"key":"3801_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/ceo.14337","volume":"52","author":"L Vidal-Oliver","year":"2024","unstructured":"Vidal-Oliver L, Montol\u00edo-Marzo E, Gallego-Pinazo R, Dolz-Marco R. Optical coherence tomography biomarkers in early and intermediate age-related macular degeneration: a clinical guide. Clin Exp Ophthalmol. 2024;52:207\u201319.","journal-title":"Clin Exp Ophthalmol"},{"key":"3801_CR69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/IAE.0000000000002815","volume":"41","author":"A Miere","year":"2021","unstructured":"Miere A, Sacconi R, Amoroso F, Capuano V, Jung C, Bandello F, et al. Sub-retinal pigment epithelium multilaminar hyperreflectivity at the onset of type 3 macular neovascularization. Retina. 2021;41:135.","journal-title":"Retina"},{"key":"3801_CR70","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/IAE.0000000000003377","volume":"42","author":"P Astroz","year":"2022","unstructured":"Astroz P, Miere A, Amoroso F, Semoun O, Khorrami A, Srour M, et al. Subretinal transient hyporeflectivity in age-related macular degeneration: a spectral domain optical coherence tomography study. Retina. 2022;42:653\u201360.","journal-title":"Retina"},{"key":"3801_CR71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.oret.2018.10.012","volume":"3","author":"Y Shi","year":"2019","unstructured":"Shi Y, Motulsky EH, Goldhardt R, Zohar Y, Thulliez M, Feuer W, et al. Predictive value of the OCT double-layer sign for identifying subclinical neovascularization in age-related macular degeneration. Ophthalmol Retin. 2019;3:211\u20139.","journal-title":"Ophthalmol Retin"},{"key":"3801_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2022.09.018","volume":"247","author":"Y Wakatsuki","year":"2023","unstructured":"Wakatsuki Y, Hirabayashi K, Yu HJ, Marion KM, Corradetti G, Wykoff CC, et al. Optical coherence tomography biomarkers for conversion to exudative neovascular age-related macular degeneration. Am J Ophthalmol. 2023;247:137\u201344.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR73","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ophtha.2019.11.007","volume":"127","author":"C Narita","year":"2020","unstructured":"Narita C, Wu Z, Rosenfeld PJ, Yang J, Lyu C, Caruso E, et al. Structural OCT signs suggestive of subclinical nonexudative macular neovascularization in eyes with large Drusen. Ophthalmology. 2020;127:637\u201347.","journal-title":"Ophthalmology"},{"key":"3801_CR74","unstructured":"Csincsik L, Muldrew KA, Bettiol A, Wright DM, Rosenfeld PJ, Waheed NK, et al. The Double Layer Sign Is Highly Predictive of Progression to Exudation in Age-Related Macular Degeneration. Ophthalmology Retina [Internet]. 2023 Oct 14 [cited 2024 Feb 4]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2468653023004980."},{"key":"3801_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-02797-5","volume":"23","author":"Y Shu","year":"2023","unstructured":"Shu Y, Ye F, Liu H, Wei J, Sun X. Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration. BMC Ophthalmol. 2023;23:83.","journal-title":"BMC Ophthalmol"},{"key":"3801_CR76","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1097\/IAE.0000000000002195","volume":"38","author":"AM Khanani","year":"2018","unstructured":"Khanani AM, Eichenbaum D, Schlottmann PG, Tuomi L, Sarraf D. Optimal management of pigment epithelial detachments in eyes with neovascular age-related macular degeneration. Retina. 2018;38:2103.","journal-title":"Retina"},{"key":"3801_CR77","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/IAE.0000000000001613","volume":"38","author":"S de Massougnes","year":"2018","unstructured":"de Massougnes S, Dirani A, Mantel I. Good visual outcome at 1 year in neovascular age-related macular degeneration with pigment epithelium detachment: factors influencing the treatment response. RETINA. 2018;38:717.","journal-title":"RETINA"},{"key":"3801_CR78","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ophtha.2014.05.009","volume":"121","author":"AC Ho","year":"2014","unstructured":"Ho AC, Busbee BG, Regillo CD, Wieland MR, Van Everen SA, Li Z, et al. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology. 2014;121:2181\u201392.","journal-title":"Ophthalmology"},{"key":"3801_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27078-x","volume":"13","author":"A Selvam","year":"2023","unstructured":"Selvam A, Singh SR, Arora S, Patel M, Kuchhal A, Shah S, et al. Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration. Sci Rep. 2023;13:68.","journal-title":"Sci Rep"},{"key":"3801_CR80","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ajo.2016.03.039","volume":"166","author":"HJ Cho","year":"2016","unstructured":"Cho HJ, Kim KM, Kim HS, Lee DW, Kim CG, Kim JW. Response of pigment epithelial detachment to anti\u2013vascular endothelial growth factor treatment in age-related macular degeneration. Am J Ophthalmol. 2016;166:112\u20139.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR81","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00417-021-05384-w","volume":"260","author":"M Cozzi","year":"2022","unstructured":"Cozzi M, Monteduro D, Parrulli S, Ristoldo F, Corvi F, Zicarelli F, et al. Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2022;260:781\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3801_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2578349","volume":"2018","author":"JH Kim","year":"2018","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Prechoroidal cleft in type 3 neovascularization: incidence, timing, and its association with visual outcome. J Ophthalmol. 2018;2018:e2578349.","journal-title":"J Ophthalmol"},{"key":"3801_CR83","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1111\/aos.15273","volume":"101","author":"G Kredi","year":"2023","unstructured":"Kredi G, Iglicki M, Gomel N, Hilely A, Loewenstein A, Habot-Wilner Z, et al. Risk factors and clinical significance of prechoroidal cleft in eyes with neovascular age-related macular degeneration in Caucasian patients. Acta Ophthalmol. 2023;101:e338\u201345.","journal-title":"Acta Ophthalmol"},{"key":"3801_CR84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1167\/iovs.09-3612","volume":"51","author":"CA Cukras","year":"2010","unstructured":"Cukras CA, Agr\u00f3n E, Klein ML, Ferris FL III, Chew EY, Gensler G, et al. Drusenoid pigment epithelial detachment as an added risk factor for disease advancement in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2010;51:96.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08626-x","volume":"12","author":"T Shijo","year":"2022","unstructured":"Shijo T, Sakurada Y, Tanaka K, Miki A, Sugiyama A, Onoe H, et al. Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment. Sci Rep. 2022;12:4715.","journal-title":"Sci Rep"},{"key":"3801_CR86","doi-asserted-by":"crossref","unstructured":"Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, et al. Towards a better understanding of non-exudative choroidal and macular neovascularization. Prog Retinal Eye Res. 2022;13:101113.","DOI":"10.1016\/j.preteyeres.2022.101113"},{"key":"3801_CR87","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/IAE.0000000000002604","volume":"40","author":"R Serra","year":"2020","unstructured":"Serra R, Coscas F, Boulet JF, Cabral D, Lupidi M, Coscas GJ, et al. Predictive activation biomarkers of treatment-naive asymptomatic choroidal neovascularization in age-related macular degeneration. RETINA. 2020;40:1224.","journal-title":"RETINA"},{"key":"3801_CR88","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ophtha.2018.08.017","volume":"126","author":"JJ Yu","year":"2019","unstructured":"Yu JJ, Agr\u00f3n E, Clemons TE, Domalpally A, van Asten F, Keenan TD, et al. Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: age-related eye disease study 2 report no. 17. Ophthalmology. 2019;126:261\u201373.","journal-title":"Ophthalmology"},{"key":"3801_CR89","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/IAE.0000000000001312","volume":"37","author":"X Wei","year":"2017","unstructured":"Wei X, Ting DSW, Ng WY, Khandelwal N, Agrawal R, Cheung CMG. Choroidal vascularity index: a novel optical coherence tomography based parameter in patients with exudative age-related macular degeneration. Retina. 2017;37:1120.","journal-title":"Retina"},{"key":"3801_CR90","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/IAE.0000000000002667","volume":"40","author":"SB Velaga","year":"2020","unstructured":"Velaga SB, Nittala MG, Vupparaboina KK, Jana S, Chhablani J, Haines J, et al. Choroidal vascularity index and choroidal thickness in eyes with reticular pseudodrusen. Retina. 2020;40:612.","journal-title":"Retina"},{"key":"3801_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100829","volume":"77","author":"R Agrawal","year":"2020","unstructured":"Agrawal R, Ding J, Sen P, Rousselot A, Chan A, Nivison-Smith L, et al. Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index. Prog Retinal Eye Res. 2020;77:100829.","journal-title":"Prog Retinal Eye Res"},{"key":"3801_CR92","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41433-022-02134-y","volume":"37","author":"S Abdolrahimzadeh","year":"2023","unstructured":"Abdolrahimzadeh S, Di Pippo M, Sordi E, Cusato M, Lotery AJ. Subretinal drusenoid deposits as a biomarker of age-related macular degeneration progression via reduction of the choroidal vascularity index. Eye. 2023;37:1365\u201370.","journal-title":"Eye"},{"key":"3801_CR93","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00417-020-04957-5","volume":"259","author":"M Pellegrini","year":"2021","unstructured":"Pellegrini M, Bernabei F, Mercanti A, Sebastiani S, Peiretti E, Iovino C, et al. Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2021;259:911\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3801_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52315-w","volume":"14","author":"G Boscia","year":"2024","unstructured":"Boscia G, Pozharitskiy N, Grassi MO, Borrelli E, D\u2019Addario M, Alessio G, et al. Choroidal remodeling following different anti-VEGF therapies in neovascular AMD. Sci Rep. 2024;14:1941.","journal-title":"Sci Rep"},{"key":"3801_CR95","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.64.13.16","volume":"64","author":"M Shen","year":"2023","unstructured":"Shen M, Zhou H, Lu J, Li J, Jiang X, Trivizki O, et al. Choroidal changes after anti-VEGF therapy in AMD eyes with different types of macular neovascularization using swept-source OCT angiography. Investig Ophthalmol Vis Sci. 2023;64:16.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR96","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjophthalmol-2018-312625","volume":"103","author":"JB Kumar","year":"2019","unstructured":"Kumar JB, Wai KM, Ehlers JP, Singh RP, Rachitskaya AV. Subfoveal choroidal thickness as a prognostic factor in exudative age-related macular degeneration. Br J Ophthalmol. 2019;103:918\u201321.","journal-title":"Br J Ophthalmol"},{"key":"3801_CR97","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ajo.2020.09.003","volume":"222","author":"P Fern\u00e1ndez-Avellaneda","year":"2021","unstructured":"Fern\u00e1ndez-Avellaneda P, Freund KB, Wang RK, He Q, Zhang Q, Fragiotta S, et al. Multimodal imaging features and clinical relevance of subretinal lipid globules. Am J Ophthalmol. 2021;222:112\u201325.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR98","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/IAE.0b03e31823fb82b","volume":"32","author":"L Padnick-Silver","year":"2012","unstructured":"Padnick-Silver L, Weinberg AB, Lafranco FP, Macsai MS. Pilot study for the detection of early exudative age-related macular degeneration with optical coherence tomography. Retina. 2012;32:1045\u201356.","journal-title":"Retina"},{"key":"3801_CR99","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41433-019-0415-1","volume":"33","author":"M Karacorlu","year":"2019","unstructured":"Karacorlu M, Sayman Muslubas I, Arf S, Hocaoglu M, Ersoz MG. Membrane patterns in eyes with choroidal neovascularization on optical coherence tomography angiography. Eye. 2019;33:1280\u20139.","journal-title":"Eye"},{"key":"3801_CR100","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/IAE.0000000000001964","volume":"39","author":"A Miere","year":"2019","unstructured":"Miere A, Butori P, Cohen SY, Semoun O, Capuano V, Jung C, et al. VASCULAR remodeling of choroidal neovascularization after anti-vascular endothelial growth factor therapy visualized on optical coherence tomography angiography. Retina. 2019;39:548\u201357.","journal-title":"Retina"},{"key":"3801_CR101","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ajo.2015.06.030","volume":"160","author":"L Kuehlewein","year":"2015","unstructured":"Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 2015;160:739\u2013748.e2.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR102","doi-asserted-by":"crossref","unstructured":"Crincoli E, Catania F, Sacconi R, Ribarich N, Ferrara S, Parravano M, et al. Deep learning for automatic prediction of early activation of treatment na\u00efve non-exudative MNVs in AMD. Retina. 2024;14.","DOI":"10.1097\/IAE.0000000000004106"},{"key":"3801_CR103","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajo.2015.04.012","volume":"160","author":"RF Spaide","year":"2015","unstructured":"Spaide RF. Optical coherence tomography angiography signs of vascular Abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol. 2015;160:6\u201316.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR104","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/IAE.0b013e3181dcfb0b","volume":"30","author":"I Barbazetto","year":"2010","unstructured":"Barbazetto I, Saroj N, Shapiro H, Wong P, Freund KB. Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab. Retina. 2010;30:1376\u201385.","journal-title":"Retina"},{"key":"3801_CR105","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2023.08.020","volume":"257","author":"AHK Nissen","year":"2024","unstructured":"Nissen AHK, Kiilgaard HC, van Dijk EHC, Hajari JN, Huemer J, Iovino C, et al. Exudative progression of treatment-na\u00efve nonexudative macular neovascularization in age-related macular degeneration: a systematic review with meta-analyses. Am J Ophthalmol. 2024;257:46\u201356.","journal-title":"Am J Ophthalmol"},{"key":"3801_CR106","doi-asserted-by":"publisher","unstructured":"Cho HJ, Kim M, Kim J, Yoon I, Park S, Kim CG Factors associated with the development of exudation in treatment-naive eyes with nonexudative macular neovascularization. Graefes Arch Clin Exp Ophthalmol. 2024 Feb 13 [cited 2024 May 1]; Available from: https:\/\/doi.org\/10.1007\/s00417-024-06384-2.","DOI":"10.1007\/s00417-024-06384-2"},{"key":"3801_CR107","doi-asserted-by":"publisher","first-page":"e0288861","DOI":"10.1371\/journal.pone.0288861","volume":"18","author":"D Pauleikhoff","year":"2023","unstructured":"Pauleikhoff D, Gunnemann ML, Ziegler M, Heimes-Bussmann B, Bormann E, Bachmeier I, et al. Morphological changes of macular neovascularization during long-term anti-VEGF-therapy in neovascular age-related macular degeneration. Plos One. 2023;18:e0288861.","journal-title":"Plos One"},{"key":"3801_CR108","first-page":"4425","volume":"64","author":"M Schranz","year":"2023","unstructured":"Schranz M, Gerendas BS, Reiter GS, Bogunovic H, Deak G, Schmidt-Erfurth U. Correlation between retinal fluid volumes and macular neovascularization parameters in neovascular AMD. Investig Ophthalmol Vis Sci. 2023;64:4425.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15139-0","volume":"12","author":"H Lee","year":"2022","unstructured":"Lee H, Kim S, Kim MA, Chung H, Kim HC. Morphology of en face Haller vessel and macular neovascularization at baseline and 3 months as predictive factors in age-related macular degeneration. Sci Rep. 2022;12:10821.","journal-title":"Sci Rep"},{"key":"3801_CR110","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/iovs.62.6.14","volume":"62","author":"M Shen","year":"2021","unstructured":"Shen M, Zhang Q, Yang J, Zhou H, Chu Z, Zhou X, et al. Swept-Source OCT angiographic characteristics of treatment-na\u00efve nonexudative macular neovascularization in AMD prior to exudation. Investig Ophthalmol Vis Sci. 2021;62:14.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3801_CR111","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/IAE.0000000000002807","volume":"41","author":"R Serra","year":"2021","unstructured":"Serra R, Coscas F, Pinna A, Cabral D, Coscas G, Souied EH. Quantitative optical coherence tomography angiography features of inactive macular neovascularization in age-related macular degeneration. Retina. 2021;41:93.","journal-title":"Retina"},{"key":"3801_CR112","doi-asserted-by":"publisher","unstructured":"Crincoli E, Catania F, Labbate G, Sacconi R, Ferrara S, Parravano M, et al. Microvascular changes in treatment na\u00efve non-exudative macular neovascularization complicated by exudation. Retina. 2022;12; https:\/\/doi.org\/10.1097\/IAE.0000000000004194.","DOI":"10.1097\/IAE.0000000000004194"},{"key":"3801_CR113","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3390\/diagnostics12112807","volume":"12","author":"H Faatz","year":"2022","unstructured":"Faatz H, Rothaus K, Ziegler M, Book M, Spital G, Lange C, et al. The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD. Diagnostics. 2022;12:2807.","journal-title":"Diagnostics"},{"key":"3801_CR114","doi-asserted-by":"publisher","first-page":"e000369","DOI":"10.1136\/bmjophth-2019-000369","volume":"4","author":"H Faatz","year":"2019","unstructured":"Faatz H, Farecki ML, Rothaus K, Gutfleisch M, Pauleikhoff D, Lommatzsch A. Changes in the OCT angiographic appearance of type 1 and type 2 CNV in exudative AMD during anti-VEGF treatment. BMJ Open Ophthalmol. 2019;4:e000369.","journal-title":"BMJ Open Ophthalmol"},{"key":"3801_CR115","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/aos.15709","volume":"102","author":"K Leth-M\u00f8ller Christensen","year":"2024","unstructured":"Leth-M\u00f8ller Christensen K, Kristjansen DB, Vergmann AS, Torp TL, Peto T, Grauslund J. Retinal vascular structure independently predicts the initial treatment response in neovascular age-related macular degeneration. Acta Ophthalmol. 2024;102:116\u201321.","journal-title":"Acta Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03801-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03801-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03801-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:01:46Z","timestamp":1748869306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03801-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3801"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03801-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MP reports personal fees from Abbvie, Novartis, Bayer, Roche, Zeiss, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}